List of articles with "Viking Therapeutics"

Viking's VK2735 Trial

Viking's VK2735 Trial

United States San Diego Viking Therapeutics obesity VK2735
CordenPharma & Viking Deal

CordenPharma & Viking Deal

Viking Therapeutics Switzerland GLP-1 Basel CordenPharma
CordenPharma and Viking Alliance

CordenPharma and Viking Alliance

USA Viking Therapeutics Basel CordenPharma GLP-1 Peptides
CordenPharma & Viking

CordenPharma & Viking

USA Viking Therapeutics GLP-1 CordenPharma
CordenPharma & Viking

CordenPharma & Viking

USA Viking Therapeutics Basel CordenPharma GLP-1 Peptides
CordenPharma and Viking

CordenPharma and Viking

USA Viking Therapeutics Basel CordenPharma GLP-1 Peptides
Viking and CordenPharma Deal

Viking and CordenPharma Deal

United States San Diego Viking Therapeutics VK2735 CordenPharma
Viking's Investor Conferences

Viking's Investor Conferences

United States Miami Viking Therapeutics VKTX metabolic disorders
Viking Therapeutics Update

Viking Therapeutics Update

United States San Diego Viking Therapeutics VK2735 VK2809
Pomerantz Investigates VKTX

Pomerantz Investigates VKTX

United States New York Pomerantz LLP Viking Therapeutics VKTX
Viking Therapeutics Alert

Viking Therapeutics Alert

United States New York Pomerantz LLP Viking Therapeutics VKTX
VK2735 Phase 2 Trial

VK2735 Phase 2 Trial

United States San Diego Viking Therapeutics Obesity Treatment VK2735
Viking at J.P. Morgan 2025

Viking at J.P. Morgan 2025

United States San Francisco J.P. Morgan Viking Therapeutics VKTX
Investigation of VKTX Claims

Investigation of VKTX Claims

USA New York Pomerantz LLP Viking Therapeutics VKTX
Viking Therapeutics Alert

Viking Therapeutics Alert

United States New York Pomerantz LLP Viking Therapeutics VK2735
Viking Therapeutics Alert

Viking Therapeutics Alert

United States New York Pomerantz LLP Viking Therapeutics VKTX
Viking Therapeutics Alert

Viking Therapeutics Alert

United States New York Pomerantz LLP Viking Therapeutics VKTX

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.